@@ -56,8 +56,40 @@ Beginning in Wave 11, the `module` column indicates which module the respondent
56
56
was randomly assigned to. See the [ survey modules and randomization] ( modules.md )
57
57
information for more details.
58
58
59
- Coding details for each survey wave follow.
59
+ ### Privacy Restrictions
60
60
61
+ To prevent respondents from being identifiable in the response data, responses
62
+ with ZIP codes with populations of 100 or fewer have their location set to ` NA ` .
63
+ This affects item A3 in the individual response files. (This change was
64
+ implemented with the introduction of Wave 4. Previously, all ZIPs were
65
+ reported.)
66
+
67
+ Invalid ZIP codes are preserved unchanged, and these rows are reported in the
68
+ individual response files with their invalid ZIPs.
69
+
70
+ ### Race and Ethnicity
71
+
72
+ Beginning in wave 4, items D6 and D7 ask respondents for race and ethnicity.
73
+ These columns are ** not** available in the microdata files due to
74
+ reidentification concerns. Public contingency tables that aggregate by race and
75
+ other demographic variables [ are available] ( contingency-tables.md ) .
76
+
77
+ Users with a specific need for these variables in microdata should contact us at
78
+ < [email protected] > to discuss options for obtaining them,
79
+ as access can be provided under some restrictions.
80
+
81
+ In the contingency tables, and in the microdata files for users who have gained
82
+ permission to access this data, the ` raceethnicity ` column is coded based on the
83
+ following rules:
84
+
85
+ * If the respondent answers "Yes" to item D6, they are coded as Hispanic,
86
+ regardless of their answer to D7. If the respondent answers "No" to D6, the
87
+ following rules apply.
88
+ * Respondents who selected more than one racial group in D7, or who selected
89
+ "Some other race", are coded as "NonHispanicMultipleOther".
90
+ * Respondents who selected only one racial group in D7 are coded according to
91
+ that race, such as "NonHispanicAsian" or
92
+ "NonHispanicAmericanIndianAlaskaNative".
61
93
62
94
## Comprehensive Codebook
63
95
@@ -91,23 +123,6 @@ Available columns:
91
123
* ` group_of_respondents_item_was_shown_to ` : Module-based subset of respondents item was asked of. One of "all" (if item was included in the [ Daily Core] ( modules.md ) and asked of all respondents), "Module A", or "Module B".
92
124
93
125
94
- ## Privacy Restrictions
95
-
96
- To prevent respondents from being identifiable in the response data, responses
97
- with ZIP codes with populations of 100 or fewer have their location set to ` NA ` .
98
- This affects item A3 in the individual response files. (This change was
99
- implemented with the introduction of Wave 4. Previously, all ZIPs were
100
- reported.)
101
-
102
- Invalid ZIP codes are preserved unchanged, and these rows are reported in the
103
- individual response files with their invalid ZIPs.
104
-
105
- Additionally, beginning in wave 4, items D6 and D7 ask respondents for race and
106
- ethnicity. These columns are ** not** available in the microdata files due to
107
- reidentification concerns. Users with a specific need for these variables should
108
- contact us at
< [email protected] > to discuss options for
109
- obtaining them. However, contingency tables that aggregate by race and other
110
- demographic variables [ are available] ( contingency-tables.md ) .
111
126
112
127
113
128
## Wave 1
@@ -471,7 +486,7 @@ new items were meant to capture reasons for vaccine hesitancy among respondents.
471
486
472
487
### New Items
473
488
474
- * Item V2a ask respondents that have received a COVID-19 vaccine and indicated
489
+ * Item V2a asks respondents that have received a COVID-19 vaccine and indicated
475
490
that they have not had 2 doses of the vaccine whether they intend to get the
476
491
required doses.
477
492
* Items V5a-V5d and V6 were added to capture reasons for respondents not
@@ -775,6 +790,11 @@ are not anticipated to change the respondent’s answer.
775
790
might become seriously ill from CVOID-19?”) was removed.
776
791
* Item C17a (“Have you had a seasonal flu vaccination since July 1, 2020?”) was
777
792
removed.
793
+ * On November 8, 2021, item V2 “How many vaccinations have you received?” was
794
+ removed from Wave 11, as the response options did not allow for respondents to
795
+ report booster shots and additional doses. Booster doses were becoming more
796
+ common at this time, making the lack of booster response options jarring to
797
+ respondents.
778
798
779
799
### Notes
780
800
@@ -789,36 +809,43 @@ are not anticipated to change the respondent’s answer.
789
809
790
810
## Wave 12
791
811
792
- Wave 12 was deployed on October 7, 2021. Deployment is in two phases:
812
+ Wave 12 was deployed on December 19, 2021, after an experimental phase in
813
+ October:
793
814
794
- * Initially the survey was given only to 15% of survey respondents, the
795
- remainder receiving Wave 11. This phase lasted until October 22. This phase
796
- was used to conduct three experiments with (1) demographic module placement,
797
- (2) vaccination uptake question, and (3) survey invitation text. Details of
798
- these experiments can be found [ below] ( #experiments ) . In data files, this is
799
- marked as wave "12.5" to distinguish from the final version.
800
- * After results of the experiments are analyzed, a final version will be
801
- deployed using only one demographic module placement and one vaccine uptake
802
- question. This will be marked as wave 12 in the data files.
815
+ * From October 7 to October 22, 2021, an experimental Wave 12 was given only to
816
+ 15% of survey respondents, the remainder receiving Wave 11. This phase was
817
+ used to conduct three experiments with (1) demographic module placement, (2)
818
+ vaccination uptake question, and (3) survey invitation text. Details of these
819
+ experiments can be found [ below] ( #experiments ) . In data files, this is marked
820
+ as wave "12.5" to distinguish from the final version. Data from the
821
+ experimental wave 12 was not included in the aggregates published in the
822
+ COVIDcast API or in our [ contingency tables] ( contingency-tables.md ) .
823
+ * After results of the experiments were analyzed, the final version was deployed
824
+ on December 19, 2021. In data files, this is marked as wave 12.
803
825
804
826
Wave 12 is available in English and the languages introduced in Wave 3.
805
827
806
828
Files:
807
829
* [ Wave 12 text and coding] (waves/CMU Survey Wave 12.pdf) (PDF)
808
830
* [ Wave 12 text and coding] (waves/CMU Survey Wave 12.docx) (Word)
809
831
810
- Besides the experiments, Wave 12 revises the schooling module of the survey
832
+ Besides the experiments, Wave 12 revised the schooling module of the survey
811
833
instrument and adds questions regarding parents’ intention to vaccinate their
812
- children (under age 18). Please review the changes carefully when you use
834
+ children (under age 18). These schooling items are part of [ Module B] ( modules.md )
835
+ of the survey. Please review the changes carefully when you use
813
836
responses from multiple waves of this survey.
814
837
838
+ ### Demographic Module Placement
839
+
840
+ In the prior waves of CTIS, respondent demographics were collected towards the
841
+ end of the survey. These questions are now asked after the vaccine module of the
842
+ survey. This placement was chosen after the [ order experiments described
843
+ below] ( #experiments ) found that this ordering improved response rates to the
844
+ demographic items. We expect this will aid users who need demographic data for
845
+ their survey analyses.
846
+
815
847
### New Items
816
848
817
- * Item V1alt asks respondents who they personally know has already received a
818
- COVID-19 vaccine. Response options include themselves, household members, and
819
- others. This is an alternate form of the item capturing vaccine uptake, and is
820
- part of the vaccination uptake question experiment described
821
- [ below] ( #experiments ) .
822
849
* Item P1 asks if the respondent is a parent or legal guardian of a child under
823
850
age 18.
824
851
* Item P2 asks respondents the age group of their oldest child. This replaces
@@ -832,16 +859,18 @@ responses from multiple waves of this survey.
832
859
* Item P6 asks respondent about the preventative measures that apply if their
833
860
oldest child is attending any in-person classes. These response options are a
834
861
subset of response options from E3 with several new additions.
862
+ * In the experimental phase, item V1alt asked respondents who they personally
863
+ know has already received a COVID-19 vaccine. Response options include
864
+ themselves, household members, and others. This is an alternate form of item
865
+ V1 capturing vaccine uptake, and is part of the vaccination uptake question
866
+ experiment described [ below] ( #experiments ) . In the final version of Wave 12,
867
+ item V1alt is not used and item V1 remains unchanged.
835
868
836
869
### Changed Items
837
870
838
871
* Item B13a asks respondents “Have you ever had coronavirus (COVID-19)?” and
839
872
replaces item B13 “As far as you know, have you ever had coronavirus
840
873
(COVID-19)?” for ease of translation.
841
- * The vaccination uptake question experiment uses questions V1 and V1alt.
842
- Subsequently, questions that use V1 in the display logic have been updated to
843
- also include respondents who are asked V1alt. The display logic has been
844
- updated for the following questions: V2, V11a, V3a, V5a, V12a, V16, and V9
845
874
* Item V5a, V5b and V5c have the following revisions to response options:
846
875
* The response option “I don’t like vaccines” was revised to “I don’t like
847
876
vaccines generally” to distinguish from a specific dislike of COVID-19
@@ -855,6 +884,11 @@ responses from multiple waves of this survey.
855
884
added: “The available appointment locations did not work for me” and “Other”
856
885
* Item V15b has two new response options: “The available appointment locations
857
886
did not work for me” and “Other”.
887
+ * The vaccination uptake question experiment, part of the experimental version
888
+ of Wave 12, used questions V1 and V1alt. During the experiment, questions that
889
+ use V1 in the display logic were updated to also include respondents who are
890
+ asked V1alt. The display logic was updated for the following questions: V2,
891
+ V11a, V3a, V5a, V12a, V16, and V9.
858
892
859
893
### Removed Items
860
894
@@ -871,41 +905,45 @@ responses from multiple waves of this survey.
871
905
872
906
Wave 12 was initially launched to 15% of respondents to collect data for the
873
907
experiments described below. (The remaining 85% continued to receive Wave 11.)
874
- After the experiments have been conducted and the data analyzed; the CTIS team
875
- will finalize the Wave 12 instrument to be distributed to the entire sample.
876
- Wave 12 will consist of three experiments with (1) demographic module placement,
877
- (2) vaccination uptake question, and (3) survey invitation text.
908
+ This experiment was run from October 7 to October 22, 2021. After the
909
+ experiments were conducted and the data analyzed, the CTIS team finalized the
910
+ Wave 12 instrument to be distributed to the entire sample. This finalized
911
+ version was deployed on December 19, 2021.
912
+
913
+ The Wave 12 trial phase consisted of three experiments with (1) demographic
914
+ module placement, (2) vaccination uptake question, and (3) survey invitation
915
+ text.
878
916
879
917
#### Demographic Module Placement and Vaccine Uptake Question
880
918
881
- The 15% of respondents who receive the experimental Wave 12 will be divided into
919
+ The 15% of respondents who received the experimental Wave 12 were divided into
882
920
three groups:
883
921
884
- * Group 1 (5% of respondents) will see the demographics questions after the
885
- symptom module, which concludes with question B2b “For how many days have you
886
- had at least one new or unusual symptom?” This group of respondents will see
887
- the Wave 11 version of the vaccine uptake question (V1).
888
- * Group 2 (5% of respondents) will see the demographics questions after the
889
- COVID vaccine module, which concludes with question V9 “How concerned are you
890
- that you would experience a side effect from a COVID-19 vaccination?” This
891
- group of respondents will see the Wave 11 version of the vaccine uptake
892
- question (V1).
893
- * Group 3 (5% of respondents) will see the experimental form of the vaccination
922
+ * Group 1 (5% of respondents) saw the demographics questions after the symptom
923
+ module, which concludes with question B2b “For how many days have you had at
924
+ least one new or unusual symptom?” This group of respondents saw the Wave 11
925
+ version of the vaccine uptake question (V1).
926
+ * Group 2 (5% of respondents) saw the demographics questions after the COVID
927
+ vaccine module, which concludes with question V9 “How concerned are you that
928
+ you would experience a side effect from a COVID-19 vaccination?” This group of
929
+ respondents saw the Wave 11 version of the vaccine uptake question (V1).
930
+ * Group 3 (5% of respondents) saw the experimental form of the vaccination
894
931
uptake question (V1alt), which asks respondents “Do you personally know anyone
895
932
who has received the COVID-19 vaccine already?” Response options include
896
- themselves, household members, and others. These respondents will not receive
897
- the previous vaccine uptake question, V1. They will see the demographic
898
- questions in the Wave 11 placement, at the end of Module A/B and before the
899
- occupation questions.
933
+ themselves, household members, and others. These respondents did not receive
934
+ the previous vaccine uptake question, V1. They saw the demographic questions
935
+ in the Wave 11 placement, at the end of Module A/B and before the occupation
936
+ questions.
900
937
901
- A new column ` w12_treatment ` in the microdata files will indicate which of the
902
- three groups above each respondent was assigned to.
938
+ A new column ` w12_treatment ` in the microdata files indicates which of the three
939
+ groups above each respondent was assigned to.
903
940
904
941
#### Survey Invitation Text
905
942
906
- Our partners at Facebook will also be conducting an experiment among those
907
- allocated to receive Wave 11. Among those participants, 6% will receive will
908
- receive one of six different invitations to the survey on their News Feed. This
909
- will be an internal Facebook experiment conducted with the goal of improving
910
- response rates and exploring additional non-response bias in the weighting
911
- process. More details will be provided when the survey invitation is finalized.
943
+ During the Wave 12 experiment period, our partners at Facebook conducted an
944
+ experiment among those respondents allocated to receive Wave 11. Among those
945
+ participants, 6% will receive will receive one of six different invitations to
946
+ the survey on their News Feed. This will be an internal Facebook experiment
947
+ conducted with the goal of improving response rates and exploring additional
948
+ non-response bias in the weighting process. More details will be provided when
949
+ the survey invitation is finalized.
0 commit comments